Technology

The Israeli mobility firm, which was founded in 2008, expects that the acquisition will help drive expansion and widen its European footprint, opening the door for its accelerated entry into Germany and positioning it to exceed €100 million (US$ 116 million) in annual revenues by the end of 2023.

New technologies described by Facebook developers at the Inside The Lab event aim to bring more people online through faster connectivity.

MeaTech is developing a sustainable alternative to industrialized animal farming by developing its proprietary cultured meat production processes based on advanced 3D bioprinting and tissue engineering technologies.

Israeli-based fantasy sports platform Funatix has been able to take advantage of the paradigm shift of how sports are consumed.

This is the 9th year in a row that Israeli firm OurCrowd was named the most active venture investor in Israel.

The US-Israeli firm plans to grow its engineering, client services and go-to-market teams, adding positions in the US, Europe and Israel.

Cloud security innovation leader Orca Security boosted its valuation by 50 percent to $1.8 billion in just seven months.

The US tech giant has plans to open five new development sites in Israel to host new employees, including in Tel Aviv, Haifa, and Jerusalem.

The third fund will support an additional 70 companies whose founders specialize in fintech, marketplaces, gaming, and proptech sectors.

The agreement was signed to help Indian and Israeli firms to implement various new technologies in agriculture, water energy and other fields.

Israel experienced a less severe decline in its startup ecosystem than that by the EU and the United States in 2020.

TailorMed was founded to help patients and the US healthcare industry tackle the financial challenges of care delivery.

The Israeli sea salt solutions company teamed up with the prestigious Northern Israeli college to help students develop new food products.

The funding will help expand Empathy’s presence across the US by releasing new products, fostering additional strategic partnerships, and growing its team.

Israeli AI company Cytoreason develops computational disease models of the human immune system for discovery and clinical drug development.